2-(4-(Sec-butyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

3,5-DIFLUORO-N-METHYLBENZAMIDE, 95%, 5g

Ethyleneglycol mono-tert-butyl ether, 99.0%, 1g

1-Bromo-5-fluoro-4-methoxy-2-nitrobenzene, 95.0%, 1g

METHYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE-2-CARBOXYLATE, 95.0%, 250mg

4-Hydroxy-5,6-dimethyl-2H-pyran-2-one, 95.0%, 1g

L-Aspartic acid b-naphthylamide, 98.0%, 1g

4-Bromo-2-chloro-n-methylaniline, 97%, 1g

ROTI® SampleLyse Soft Tissue 1, 250 pcs 250 pcs

2-hydroxy-3,3-dimethylbicyclo[2.2.1]heptane-1-carboxylic acid, 95.0%, 500mg

4-Chloro-5-fluoro-6-methoxy-2-methylpyrimidine, 95.0%, 250mg

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 95.0%, 10g

2-hydrazinyl-4,6-dimethoxypyrimidine, 95.0%, 500mg